Although CD46 is abundantly expressed on glioma cells, facilitating efficient infection, some glioma cell lines show resistance to oncolysis after the viral entry, indicating that other processes can affect its oncolytic efficacy [123]. Here, CD46 is linked to central nervous system cancer.